Cargando…

Pyk2 promotes tumor progression in renal cell carcinoma

Proline-rich tyrosine kinase 2 (Pyk2), a member of the focal adhesion kinase family, has recently been associated with tumor development. However, the role of Pyk2 in renal cell carcinoma (RCC) remains unexplored. The present study investigated the expression pattern, clinical significance, and func...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Tangliang, Bao, Yi, Lu, Xin, He, Yi, Gan, Xinxin, Wang, Jianchao, Liu, Bing, Wang, Linhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176372/ https://www.ncbi.nlm.nih.gov/pubmed/30344745 http://dx.doi.org/10.3892/ol.2018.9412

Ejemplares similares

DNA methylation-regulated QPCT promotes sunitinib resistance by increasing HRAS stability in renal cell carcinoma
por: Zhao, Tangliang, et al.
Publicado: (2019)

Cell Adhesion-Related Molecules Play a Key Role in Renal Cancer Progression by Multinetwork Analysis
por: Wang, Anbang, et al.
Publicado: (2019)

QPCT regulation by CTCF leads to sunitinib resistance in renal cell carcinoma by promoting angiogenesis
por: Zhao, Tangliang, et al.
Publicado: (2021)

Long noncoding RNA EGFR-AS1 promotes cell growth and metastasis via affecting HuR mediated mRNA stability of EGFR in renal cancer
por: Wang, Anbang, et al.
Publicado: (2019)

Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis
por: Jiang, Aimin, et al.
Publicado: (2022)

DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma
por: Bao, Yewei, et al.
Publicado: (2021)

Establishment of a prognosis Prediction Model Based on Pyroptosis-Related Signatures Associated With the Immune Microenvironment and Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2021)

Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombus
por: Gu, Yufeng, et al.
Publicado: (2023)

Angiopoietin-like protein 3 blocks nuclear import of FAK and contributes to sorafenib response
por: Bao, Yi, et al.
Publicado: (2018)

High expression of PYK2 is associated with poor prognosis and cancer progression in early-stage cervical carcinoma
por: Zhang, Can, et al.
Publicado: (2022)

EGFR-AS1 Promotes Bladder Cancer Progression by Upregulating EGFR
por: Wang, Anbang, et al.
Publicado: (2020)

The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence
por: Sun, C K, et al.
Publicado: (2007)

Pyk2 for perfect bones
por: LeBrasseur, Nicole
Publicado: (2007)

A feed-forward loop between nuclear translocation of CXCR4 and HIF-1α promotes renal cell carcinoma metastasis
por: Bao, Yi, et al.
Publicado: (2018)

Pyk2 regulates sepsis-induced lung injury via ferroptosis
por: Wang, Jia, et al.
Publicado: (2023)

Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC
por: Huang, Chengmei, et al.
Publicado: (2021)

PYK2 promotes HER2-positive breast cancer invasion
por: Al-Juboori, Shaymaa IK., et al.
Publicado: (2019)

Role of Pyk2 in Human Cancers
por: Shen, Ting, et al.
Publicado: (2018)

Impact of the Whole Genome Duplication Event on PYK Activity and Effects of a PYK1 Mutation on Metabolism in S. cerevisiae
por: Chen, Hong, et al.
Publicado: (2021)

Identification of Immune-Related Cells and Genes in Tumor Microenvironment of Clear Cell Renal Cell Carcinoma
por: Du, Bowen, et al.
Publicado: (2020)

Pyruvate Kinase M2 Contributes to TLR-Mediated Inflammation and Autoimmunity by Promoting Pyk2 Activation
por: Zhang, Xin, et al.
Publicado: (2021)

Novel Role of Src in Priming Pyk2 Phosphorylation
por: Zhao, Ming, et al.
Publicado: (2016)

The Role of Proline Rich Tyrosine Kinase 2 (Pyk2) on Cisplatin Resistance in Hepatocellular Carcinoma
por: Geng, Wei, et al.
Publicado: (2011)

Cell aggregation induces phosphorylation of PECAM-1 and Pyk2 and promotes tumor cell anchorage-independent growth
por: Zhang, Xing, et al.
Publicado: (2010)

Sema4D/Plexin-B1 promotes the progression of osteosarcoma cells by activating Pyk2-PI3K-AKT pathway
por: Li, Changhui, et al.
Publicado: (2021)

Methyltransferase‐like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1
por: Liu, Tao, et al.
Publicado: (2021)

Pyk2/MCU Pathway as a New Target for Reversing Atherosclerosis
por: Zhang, Yingzhen, et al.
Publicado: (2021)

Convergent Effects of Resveratrol and PYK2 on Prostate Cells
por: Conte, Andrea, et al.
Publicado: (2016)

PYK2 at the Intersection of Signaling Pathways in Pancreatic Cancer
por: Means, Anna L.
Publicado: (2019)

Tyrosine 402 Phosphorylation of Pyk2 Is Involved in Ionomycin-Induced Neurotransmitter Release
por: Zhang, Zhao, et al.
Publicado: (2014)

TRPC channel-mediated neuroprotection by PDGF involves Pyk2/ERK/CREB pathway
por: Yao, Honghong, et al.
Publicado: (2009)

Hematopoietic Pyk2 regulates migration of differentiated HL-60 cells
por: Wang, Lin, et al.
Publicado: (2010)

KRT8 upregulation promotes tumor metastasis and is predictive of a poor prognosis in clear cell renal cell carcinoma
por: Tan, Hai-Song, et al.
Publicado: (2017)

CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types
por: Jiang, Aimin, et al.
Publicado: (2022)

Hydrogen Sulfide Recruits Macrophage Migration by Integrin β1-Src-FAK/Pyk2-Rac Pathway in Myocardial Infarction
por: Miao, Lei, et al.
Publicado: (2016)

Suppression of Pyk2 Kinase and Cellular Activities by Fip200
por: Ueda, Hiroki, et al.
Publicado: (2000)

Pyk2 Regulates MAMs and Mitochondrial Dynamics in Hippocampal Neurons
por: López-Molina, Laura, et al.
Publicado: (2022)

Proline-Rich Tyrosine Kinase 2 (Pyk2) Promotes Cell Motility of Hepatocellular Carcinoma through Induction of Epithelial to Mesenchymal Transition
por: Sun, Chris K., et al.
Publicado: (2011)

Targeting FAK/PYK2 with SJP1602 for Anti-Tumor Activity in Triple-Negative Breast Cancer
por: Jeon, Myeongjin, et al.
Publicado: (2023)

Siglec-15 promotes progression of clear renal cell carcinoma
por: Yang, Wen-Bo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h8ooo89i5kjecm8s9r81ek59co